Corrigendum to PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study Volume 14, Issue 3, May–June 2020, Pages 322-330.e5
Titel:
Corrigendum to PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study Volume 14, Issue 3, May–June 2020, Pages 322-330.e5
Auteur:
Daniels, Stephen Caprio, Sonia Chaudhari, Umesh Manvelian, Garen Baccara-Dinet, Marie T. Brunet, Aurelie Scemama, Michel Loizeau, Virginie Bruckert, Eric